Human Carbonic Anhydrase IX Quantikine ELISA Kit
| Name | Human Carbonic Anhydrase IX Quantikine ELISA Kit |
|---|---|
| Supplier | R&D Systems |
| Catalog | DCA900 |
| Category | ELISA Kit |
| Prices | $509.00 |
| Sizes | 1 kit |
| Assay Type | Solid Phase Sandwich ELISA |
| Sample Type | Cell Culture Supernates (100 uL), Serum (100 uL), EDTA Plasma (100 uL), Heparin Plasma (100 uL), Citrate Plasma (100 uL), Urine (100 uL) |
| Sensitivity | 4.39 pg/mL |
| Range | 15.6 - 1,000 pg/mL (Cell Culture Supernates, Serum, EDTA Plasma, Heparin Plasma, Citrate Plasma, Urine) |
| Format | 96-well strip plate |
| Applications | ELISA |
| Species Reactivities | Human |
| Description | The Quantikine Human Carbonic Anhydrase IX Immunoassay is a 4.5 hour solid-phase ELISA designed to measure human CA9 in cell culture supernates, serum, plasma, and urine |
| Gene | CA9 |
| Supplier Page | Shop |
Product images
Product References
DNA-linked Inhibitor Antibody Assay (DIANA) for sensitive and selective enzyme - DNA-linked Inhibitor Antibody Assay (DIANA) for sensitive and selective enzyme
Navratil V, Schimer J, Tykvart J, Knedlik T, Vik V, Majer P, Konvalinka J, Sacha P. Nucleic Acids Res. 2017 Jan 25;45(2):e10.
A multiplex immunoassay for the non-invasive detection of bladder cancer. - A multiplex immunoassay for the non-invasive detection of bladder cancer.
Shimizu Y, Furuya H, Bryant Greenwood P, Chan O, Dai Y, Thornquist MD, Goodison S, Rosser CJ. J Transl Med. 2016 Jan 30;14:31.
A multi-analyte assay for the non-invasive detection of bladder cancer. - A multi-analyte assay for the non-invasive detection of bladder cancer.
Goodison S, Chang M, Dai Y, Urquidi V, Rosser CJ. PLoS One. 2012;7(10):e47469.
Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase - Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase
Sim SH, Messenger MP, Gregory WM, Wind TC, Vasudev NS, Cartledge J, Thompson D, Selby PJ, Banks RE. Br J Cancer. 2012 Sep 25;107(7):1131-7.
Measuring carbonic anhydrase IX as a hypoxia biomarker: differences in - Measuring carbonic anhydrase IX as a hypoxia biomarker: differences in
Wind TC, Messenger MP, Thompson D, Selby PJ, Banks RE. Ann Clin Biochem. 2011 Mar;48(Pt 2):112-20.
Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy - Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy
de Groot JF, Piao Y, Tran H, Gilbert M, Wu HK, Liu J, Bekele BN, Cloughesy T, Mehta M, Robins HI, Lassman A, DeAngelis L, Camphausen K, Chen A, Yung WK, Prados M, Wen PY, Heymach JV. Clin Cancer Res. 2011 Jul 15;17(14):4872-81.
High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers - High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers
Ilie M, Mazure NM, Hofman V, Ammadi RE, Ortholan C, Bonnetaud C, Havet K, Venissac N, Mograbi B, Mouroux J, Pouyssegur J, Hofman P. Br J Cancer. 2010 May 25;102(11):1627-35.
Expression of carbonic anhydrase 9, a potential intrinsic marker of hypoxia, is - Expression of carbonic anhydrase 9, a potential intrinsic marker of hypoxia, is
Tanaka N, Kato H, Inose T, Kimura H, Faried A, Sohda M, Nakajima M, Fukai Y, Miyazaki T, Masuda N, Fukuchi M, Kuwano H. Br J Cancer. 2008 Nov 4;99(9):1468-75.